SALES GROWTH IN CHINA REPORTED BY THE GLOBAL LEADER FOR MOLECULAR BEAM EPITAXY
Riber and a Chinese institute signed a significant sales contract at the end of September in relation to two new Compact21 systems.
The two systems will be dedicated to research on new generation compound semi-conductors. Already a user of several Riber systems, the purchasing laboratory wished to strengthen its research and development capacities to meet rising demand for studies in China. With this outlook in mind, it will continue to rely on what they consider to be the best MBE system for research in the market.
This further sale to a recurring customer confirms the quality of Riber’s Compact 21 systems, as well as the excellence of the technical support provided.
Having sold about forty systems to date in China, Riber confirms the significant development of the MBE technology in the region. Its penetration of the Chinese market, with 70% of MBE systems installed in the country was further reinforced by the opening in April 2009 of a permanent sales office in Shanghai.
Riber intends to continue increasing sales in China by stepping up the local workforce, especially in the technical support area.
SHAREHOLDERS’ AGENDA: Sales to September 30, 2009, November 5 after close of trading.
Riber designs and produces molecular beam epitaxy (MBE) systems as well as evaporation sources and cells for the semi-conductor industry. This high-technology equipment is essential for the manufacture of compound semi-conductor materials and new materials that are used in numerous consumer applications such as new Information Technologies, OLED flat screens and the new generation of solar cells.
Riber SA’s shares are listed in Compartment “C" of the Euronext Paris Stock Exchange and are a component of the CAC IT index.
ISIN Code: FR0000075954 Reuters Code: RIBE.PA Bloomberg Code: RIB.FP
Riber has been awarded the OSEO innovation certification, enabling it to qualify for FCPIs (French mutual funds).
Tel: +33 (0)1 39 96 65 00
Tel: +33 (0)1 53 65 68 68